Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial
scientific article published on 7 August 2014
Author/s
author: Philippe Gabriel Steg, Kenneth W Mahaffey, Matthew T Roe, Robert A Harrington, Pierluigi Tricoci, Andreas Zeiher, Deepak L. Bhatt, J Wouter Jukema, Harvey White, Lisa G Berdan, Shaun G Goodman, Tyrus L Rorick, Vera Bittner, Corinne Hanotin, Angèle Moryusef, Robert Pordy, William J. Sasiela, Jean-François Tamby
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.